BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11850073)

  • 1. Cytogenetic characterization of diffuse large cell lymphoma using multi-color fluorescence in situ hybridization.
    Dave BJ; Nelson M; Pickering DL; Chan WC; Greiner TC; Weisenburger DD; Armitage JO; Sanger WG
    Cancer Genet Cytogenet; 2002 Jan; 132(2):125-32. PubMed ID: 11850073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetics and fluorescence in situ hybridization studies of diffuse large B-cell lymphoma in children and young adults.
    Dave BJ; Weisenburger DD; Higgins CM; Pickering DL; Hess MM; Chan WC; Sanger WG
    Cancer Genet Cytogenet; 2004 Sep; 153(2):115-21. PubMed ID: 15350300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas.
    Cigudosa JC; Parsa NZ; Louie DC; Filippa DA; Jhanwar SC; Johansson B; Mitelman F; Chaganti RS
    Genes Chromosomes Cancer; 1999 Jun; 25(2):123-33. PubMed ID: 10337996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive cytogenetic analysis including multicolor spectral karyotyping and interphase fluorescence in situ hybridization in lymphoma diagnosis. a summary of 154 cases.
    Fan YS; Rizkalla K
    Cancer Genet Cytogenet; 2003 May; 143(1):73-9. PubMed ID: 12742158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New chromosome abnormalities and lack of BCL-6 gene rearrangements in Argentinean diffuse large B-cell lymphomas.
    Cerretini R; Noriega MF; Narbaitz M; Slavutsky I
    Eur J Haematol; 2006 Apr; 76(4):284-93. PubMed ID: 16519699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectral karyotyping identifies new rearrangements, translocations, and clinical associations in diffuse large B-cell lymphoma.
    Nanjangud G; Rao PH; Hegde A; Teruya-Feldstein J; Donnelly G; Qin J; Jhanwar SC; Zelenetz AD; Chaganti RS
    Blood; 2002 Apr; 99(7):2554-61. PubMed ID: 11895793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome abnormalities in diffuse large B-cell lymphomas: analysis of 231 Chinese patients.
    Zhao X; Fan R; Lin G; Wang X
    Hematol Oncol; 2013 Sep; 31(3):127-35. PubMed ID: 23135954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic analysis of 147 cases of non-Hodgkin's lymphoma: non-random chromosomal abnormalities and histological correlations.
    Juneja S; Lukeis R; Tan L; Cooper I; Szelag G; Parkin JD; Ironside P; Garson OM
    Br J Haematol; 1990 Oct; 76(2):231-7. PubMed ID: 2094325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression.
    Nanjangud G; Rao PH; Teruya-Feldstein J; Donnelly G; Qin J; Mehra S; Jhanwar SC; Zelenetz AD; Chaganti RS
    Cytogenet Genome Res; 2007; 118(2-4):337-44. PubMed ID: 18000388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: comparison between CD5-positive and CD5-negative cases.
    Tagawa H; Tsuzuki S; Suzuki R; Karnan S; Ota A; Kameoka Y; Suguro M; Matsuo K; Yamaguchi M; Okamoto M; Morishima Y; Nakamura S; Seto M
    Cancer Res; 2004 Sep; 64(17):5948-55. PubMed ID: 15342373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of chromosomal alteration of 3q27 on nodal B-cell lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 329 consecutive patients.
    Niitsu N; Okamoto M; Nakamura N; Nakamine H; Aoki S; Hirano M; Miura I
    Leuk Res; 2007 Sep; 31(9):1191-7. PubMed ID: 17197022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL) reveals gain at 1q31 and RGS1 encoding protein; high RGS1 immunohistochemical expression associates with poor overall survival in DLBCL not otherwise specified (NOS).
    Carreras J; Kikuti YY; Beà S; Miyaoka M; Hiraiwa S; Ikoma H; Nagao R; Tomita S; Martin-Garcia D; Salaverria I; Sato A; Ichiki A; Roncador G; Garcia JF; Ando K; Campo E; Nakamura N
    Histopathology; 2017 Mar; 70(4):595-621. PubMed ID: 27775850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of 3q27 chromosomal abnormality in diffuse large B cell lymphoma using FISH on cell microarray].
    Jiang HY; Li HL; Zhao T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):73-7. PubMed ID: 18247310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment.
    Offit K; Jhanwar SC; Ladanyi M; Filippa DA; Chaganti RS
    Genes Chromosomes Cancer; 1991 May; 3(3):189-201. PubMed ID: 1868033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B-cell lymphomas with MYC rearrangement.
    Havelange V; Ameye G; Théate I; Callet-Bauchu E; Mugneret F; Michaux L; Dastugue N; Penther D; Barin C; Collonge-Rame MA; Baranger L; Terré C; Nadal N; Lippert E; Laï JL; Cabrol C; Tigaud I; Herens C; Hagemeijer A; Raphael M; Libouton JM; Poirel HA;
    Genes Chromosomes Cancer; 2013 Jan; 52(1):81-92. PubMed ID: 23012230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.
    Le Gouill S; Talmant P; Touzeau C; Moreau A; Garand R; Juge-Morineau N; Gaillard F; Gastinne T; Milpied N; Moreau P; Harousseau JL; Avet-Loiseau H
    Haematologica; 2007 Oct; 92(10):1335-42. PubMed ID: 18024371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicolour fluorescence in situ hybridization analysis of t(14;18)-positive follicular lymphoma and correlation with gene expression data and clinical outcome.
    Lestou VS; Gascoyne RD; Sehn L; Ludkovski O; Chhanabhai M; Klasa RJ; Husson H; Freedman AS; Connors JM; Horsman DE
    Br J Haematol; 2003 Sep; 122(5):745-59. PubMed ID: 12930384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interphase cytogenetic analysis of lymphoma-associated chromosomal breakpoints in primary diffuse large B-cell lymphomas of the central nervous system.
    Montesinos-Rongen M; Zühlke-Jenisch R; Gesk S; Martín-Subero JI; Schaller C; Van Roost D; Wiestler OD; Deckert M; Siebert R
    J Neuropathol Exp Neurol; 2002 Oct; 61(10):926-33. PubMed ID: 12387458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL2 gene aberration as an IPI-independent marker for poor outcome in non-germinal-centre diffuse large B cell lymphoma.
    Obermann EC; Csato M; Dirnhofer S; Tzankov A
    J Clin Pathol; 2009 Oct; 62(10):903-7. PubMed ID: 19783718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunophenotyping and molecular genetic analysis of diffuse large B-cell lymphoma].
    Han YS; Xue YQ; Yang HY; Zhang J; Pan JL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):143-7. PubMed ID: 23568722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.